Sanofi should hear from the FDA in September about its application for Sarclisa as a first-line therapy for multiple myeloma after the US regulator gave it a priority review. The French pharma group ...

In this video, Hamza Hassan, MD, assistant professor of oncology at Roswell Park Comprehensive Cancer Center, discusses the second-line of treatment for this case. Editor's note: The following is an ...

A former headmaster, who dedicated his life “man and boy” to one of the world’s oldest private schools in the country has died.